Literature DB >> 399385

An evaluation of pertussis vaccine.

E A Mortimer, P K Jones.   

Abstract

Infant mortality from pertussis in the United States was 4.5 deaths/1,000 in 1900 but decreased to 0.003 deaths/1,000 by 1974. The attribution of this decrease in mortality to the widespread use of pertussis vaccine, which began in the 1940s, has been questioned because death rates from pertussis in infants steadily declined by 70% between 1900-1904 and 1935-1939. Thes doubts are compounded by the uncertain frequency and significance of untoward reactions to the vaccine. An attempt was made to clarify this issue by statistical analysis. Because most deaths from pertussis occur in the young, death rates were determined for consecutive five-year periods from 1900 through 1974 among children younger than one year of age (infants) and among those from one to four years of age. there was an accelerated decline in mortality beginning in 1940, especially among infants (P < 0.01 vs. mortality in 1930-1939). On the basis of the rate of decline before 1940, 4,000-8,000 deaths from pertussis would be expected to hve occurred in 1970-1974; however, only 52 such deaths occurred. It is unlikely that factors other than pertussis vaccine caused this decline in mortality. Therefore, the vaccine's benefit-risk ratio probably is high.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 399385     DOI: 10.1093/clinids/1.6.927

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

1.  Pertussis: epidemiology and control.

Authors:  A S Muller; J Leeuwenburg; D S Pratt
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

2.  The severity of whooping cough in hospitalised children--is it declining?

Authors:  I D Johnston; H R Anderson; H P Lambert
Journal:  J Hyg (Lond)       Date:  1985-04

3.  How are the sub-unit pertussis vaccines to be evaluated?

Authors:  D N Baxter; A C Gibbs
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

Review 4.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Reading attainment and physical development after whooping cough.

Authors:  I D Johnston; H R Anderson; H P Lambert; S Patel
Journal:  J Epidemiol Community Health       Date:  1985-12       Impact factor: 3.710

7.  The pertussis vaccine controversy.

Authors:  A R Hinman
Journal:  Public Health Rep       Date:  1984 May-Jun       Impact factor: 2.792

Review 8.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 9.  The past, present, and future of pertussis. The role of adults in epidemiology and future control.

Authors:  J D Cherry; L J Baraff; E Hewlett
Journal:  West J Med       Date:  1989-03

Review 10.  Global Childhood Deaths From Pertussis: A Historical Review.

Authors:  Maria Yui Kwan Chow; Gulam Khandaker; Peter McIntyre
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.